Listar por autor "Rivero, A."
Mostrando ítems 1-3 de 3
-
Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb/V and dialysis in Spanish clinical practice – preliminary data Vie-KinD study
Londoño, M.C.; García-Buey, L.; Mallolas, J.; Barril, Guillermina; Ahumada, A.; Riveiro-Barciela, M.; Muñoz-Gómez, R.; Roget, M.; Serra, M.A.; Devesa, M.J.; Navascues, C.; Baliellas, Carme; Aldamiz-Echevarría, T.; Gutiérrez, M.L.; Carmona, I.; Polo-Lorduy, B.; Bonet, L.; García-Samaniego, J.; Jiménez, M.; Prieto Castillo, Martín; Moran, S.; Castro-Iglesias, Ángeles; Delgado, M.; Gea, F.; Martín-Granizo, I.; Montes, M.; Morano, Luis; Castaño, M.A.; De los Santos, I.; Laguno, M.; Losa-García, Juan E.; Montero, M.; Rivero, A.; Manzanares, A.; De Álvaro, C. (Elsevier, 2017) -
Hepatitis E 3ra genotype infection in people living with HIV in Spain
Rivero-Juárez, A.; Frías, Mario; López-López, Pedro; Berenguer, Juan; García, Federico; Macías, Juan; Alcaraz, Begoña; Castro-Iglesias, Ángeles; Caballero-Gómez, Javier; Rivero, A. (Frontiers, 2020-09-11)[Abstract] Background: The objective of our study was to assess the prevalence and incidence of HEV in people living with HIV (PLWH) in a Spanish national cohort. Methods: Retrospective longitudinal study including PLWH ... -
Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin
Monje-Agudo, P.; Castro-Iglesias, Ángeles; Rivero-Juárez, A.; Martínez-Marcos, F.; Ortega-González, E.; Real, L.M.; Pernas, Berta; Merchante, N.; Cid-Silva, Purificación; Macías, Juan; Merino, M.D.; Rivero, A.; Mena, Álvaro; Neukam, K.; Pineda, J.A. (Springer, 2015-07-09)[Abstract] It is commonly accepted that human immunodeficiency (HIV) coinfection negatively impacts on the rates of sustained virological response (SVR) to therapy with pegylated interferon plus ribavirin (PR). However, ...
